Clinical Trial Update: A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating LY3841136 versus placebo in adults with obesity or overweight has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• LY3841136

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight and Obesity | Phase 2 | Status: COMPLETED